UK Government Funding Development of Sequencing-Based Cancer Tests
June 21, 2011
UK Government Funding Development of Sequencing-Based Cancer Tests
Three UK-funded projects, led by Life Technologies, Source BioScience, and Oxford Gene Technologies, aim to develop tests based on several platforms, including the Ion Torrent PGM and Illumina HiSeq.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Oxford Group Launches PGM-Based Cancer Test under UK's Stratified Medicine Program
January 2, 2013 / Clinical Sequencing News - Foundation Medicine Shows Sequencing-based Cancer Test Can ID Clinically Actionable Mutations
June 8, 2011 / Clinical Sequencing News - Targeted Deep Sequencing Method Detects Rare Mutations in Circulating Tumor DNA
June 6, 2012 / Clinical Sequencing News - Foundation Medicine Raises $10M, En Route to Launching Targeted Sequencing Test for Cancer Dx
August 24, 2011 / Clinical Sequencing News - Targeted Sequencing Panels Gaining Ground for Cancer Dx
August 17, 2011 / Clinical Sequencing News